Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

8,970 public trials 1,744 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Completed

Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

NCT00104013

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Neurological Physicians of Arizona, Inc. Mesa, Arizona, United States
  • Pivotal Research Centers Mesa, Arizona, United States
  • Pivotal Research Centers Peoria, Arizona, United States
  • Northwest NeuroSpecialists Tucson, Arizona, United States
View all 41 locations
View Trial Details
Completed

European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients

NCT00357357

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations
  • King George Hospital Visakhapatnam, ANDH PRAD, India
  • Manipal Hospital, Bangalore, Karna, India
  • Sree Chitra Tirunal Institute for Medical Sciences and Technology Thiruvananthapuram, Kerala, India
  • Nizam's Institute of Medical Sciences, Hyderabaad, Panjagutta, India
View Trial Details
Completed

18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

NCT00103649

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • UAB Memory Disorders Clinic Birmingham, Alabama, United States
  • Barrow Neurology Clinics Phoenix, Arizona, United States
  • PsyPharma Clinical Research, Inc. Phoenix, Arizona, United States
  • Radiant Research Scottsdale, Arizona, United States
View all 121 locations
View Trial Details
Completed

Ascorbic Acid Treatment in CMT1A Trial (AATIC)

NCT00271635

Conditions
Charcot-Marie-Tooth Disease, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Department of Neurology Academic Medical Center University of Amsterdam Amsterdam, P.O.Box 22660, Netherlands
View Trial Details
Completed

A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis

NCT00683969

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Sun City, Arizona, United States
  • Sacramento, California, United States
  • Miami, Florida, United States
  • Kansas City, Kansas, United States
View all 43 locations
View Trial Details

Related conditions